Empowering the next generation for kidney health advancement worldwide: the Young Nephrologists Committee of the International Society of Nephrology
doi.org/10.1016/j.kint.2025.11.003
#MedSky #NephSky @sabinekaram.bsky.social @theisn.org
The debate about kidney function estimation in cancer patients is not over. What is important to remember is that mCrCl is not mGFR
Le congrès de la #SFNDT2025 est lancé ! IRA et immunothérapie : la place de la biopsie rénale reste primordial pour ajuster les traitements par @sabinekaram.bsky.social #SFNDT #TOURS
Light Chain MGUS Calculator
#Onconephrology π¦ #Nephpearls #NephSky
H/T @sabinekaram.bsky.social
π± istopmm.com/lcmgus/
π pubmed.ncbi.nlm.nih.gov/36100605/
β¨ From data to dialogue: Explore kidney care worldwide with the ISN-GKHA Interactive Map πΊοΈ
π Compare countries
π Spot care gaps
π Drive global change
Start exploring β‘οΈ http://lite.spr.ly/6... #UKKW2025 #PodocyteConference2025
Dialysis facilities face unique challenges during disasters.
The Humanitarian Kidney Support Initiative module offers dialysis staff practical guidance to maintain essential care during natural or human-made emergencies.
Explore and complete the module: bit.ly/3ZzoAMD
β³ Last days to apply!
Early-career nephrologists from LMICs: Apply by June 1 for the ISN Interventional Nephrology Scholarship.
π©Ί Hands-on training
π 17 global centers
πΈ Travel & living costs covered
π Learn more: http://lite.spr.ly/6...
Because #KidneyHealthMatters @theisn.org is advocating for the global community at #WHA78
Do not miss this capacity-building webinar in research curated with love by the @theisn.org young nephrologist committee #ISNyoung with renowned experts in the field
ISN Quiz alert!!
πHTN remains the leading global contributor to reno cardiovascular death and disability.
πTake this evidence-based quiz from ISN SoMe team members to assess your knowledge and improve patient care. Hereβs the link for the quiz: theisn.outgrow.us/HTN_2025
Happy to share our case based onconephrology web series @isnkidneycare.bsky.social
Expand your expertise in complex cancer-related kidney disease casesΒ Β - International Society of Nephrology
@sabinekaram.bsky.social
t.co/J8eU9klFnc
π§°New tools for early ICI-AKI detection!
π§Urine, π©Έ serum, and πΈ imaging markers are changing the game.
Protect kidneys π« , save lives!π±
π doi.org/10.34067/KID...
@asnpublications.bsky.social K360
@sabinekaram.bsky.social et al
#Nephrology #OncoNephrology #AKI #NephSky #MedSky
#NephPearls
Do not miss this webinar to learn about the deaign and appraisal of kidney trials with world experts. Free registration @theisn.org #ISNyoung
Metformin is both safe and effective in advanced CKD with its discontinuation porentially increasing mortality
is contrast nephropathy in the room with us right now?
another article showing that contrast nephropathy isnβt a thing
I wonder how long these articles will keep getting published, since I kinda thought this was settled π€·ββοΈ
https://www.jem-journal.com/article/S0736-4679(24)00372-X/abstract #EMIMCC
βThus, the apparent reduction in the incidence of AKI in the PROTECTION trial may be more an ephemera than a meaningful clinical benefit.β
Paul Palevsky
#NephSky
(Also, read the whole thing)
Dr Talerβs approach to resistant HTN. Evaluate for pseudoresistance, always consider clues for secondary HTN and selectively test, ALWAYS check aldo/renin possibly during initial visit ( if no MRA or amiloride), Use longer acting meds, add SGLT if CKD or DM, MRA of course, then other meds depending
Strengthening ties to advance regional and global kidney care: ISN Affiliated societies meet at WCNβ25 http://lite.spr.ly/6... #ISNWCN
Growing and learning with young nephrologists worldwide: A message of gratitude, by @sabinekaram.bsky.social @http://lite.spr.ly/6001GDpB, immediate past chair of the ISN Young Nephrologists Committee http://lite.spr.ly/6... #ISNyoung
Stellar lesson of advocacy today given by @cervantes-lily1.bsky.social who makes the impossible happen, so pertinent on #Worldkidneyday
I so agree with you. This is called statistical manipulation of the crowd
Amazing paper to read for anybody interested in implementation science and equity by @cervantes-lily1.bsky.social
ππ‘π¦ππππ§, our newsletter is out! Read about:
β’ How to get involved in #WorldKidneyDay
β’ ISN Academy Rare Kidney Diseases CME-accredited training
β’ New 12 ISN Fellows
β’ βGrowing and learning with young nephrologists worldwideβ by @sabinekaram.bsky.social
β’ and more
www.theisn.org/news/insight...
#ECNeph Do join us today for an interesting case discussion at 9.30 PM IST @myadla.bsky.social @ferarceamare.bsky.social @theisn.org @dilushiwijay.bsky.social @nephromythri.bsky.social @karnephro.bsky.social @sabinekaram.bsky.social @arvindcanchi.bsky.social @sreejithdr.bsky.social
π¨ #Tweetorial Alert! π¨
π¬ Rare Kidney Diseases: Unmasking the Zebras in Nephrology! π¦π‘
Join me, Dr. Mythri Shankar, @nephromythri.bsky.social as we explore fascinating, rare kidney diseasesβbecause not every kidney case is a horse! π
Stay tuned! π§΅π #NephTwitter #RareKidneyDiseases #MedEd
Serve the date for this webinar that will make primary care physicians master anything related to proteinuria! @theisn.org
PA in Resistant Hypertension: A Hidden Epidemic?
π Up to 22% prevalence in resistant hypertension!
π Increases with age
π± Even 11% of normotensives have a high aldosterone signature!
π¨ #NephJC
A new prognostic test incorporates biomarkers and clinical data approved by the FDA to assess the risk of progressive decline in kidney function in individuals with type 2 diabetes and CKD stages G1-3b. bit.ly/JASN0644
#ASNJASN
Cancer diagnosis and prognosis after initiation of hemodialysis: multicenter Japan CANcer and DialYsis (J-CANDY) study academic.oup.com/ckj/article/... @kdjhaveri.bsky.social @ckj-era.bsky.social
Sarees were the highlight of the #ISNWCN congress: bringing women from all over the world in a unique march of love together @theisn.org
Thank you #WININDIA
